EID Parry India gives trendline breakout
EID Parry India gives trendline breakout

EID Parry India gives trendline breakout

Vinayak Gangule Article rating: 3.5

Considering the daily timeframe, the stock of EID Parry India Limited has given a breakout of downward sloping trendline resistance, formed by connecting swing highs since August 2020.

Buzzing stock: Ashok Leyland rises by 9.83 per cent
Buzzing stock: Ashok Leyland rises by 9.83 per cent

Buzzing stock: Ashok Leyland rises by 9.83 per cent

Ganesh V Article rating: 4.3

Ashok Leyland, the flagship company of the Hinduja Group and India’s leading commercial vehicle manufacturer, today launched the BADA DOST.

Yes Bank rises after ICRA upgrade ratings on debt instrument
Yes Bank rises after ICRA upgrade ratings on debt instrument

Yes Bank rises after ICRA upgrade ratings on debt instrument

Ganesh V Article rating: 3.8

Yes Bank rose 2.67 per cent to Rs 15 after domestic credit rating agency ICRA on Friday upgraded its ratings assigned to various debt instruments of the private lender.

Trailing returns or rolling returns: Which one to choose?
Trailing returns or rolling returns: Which one to choose?

Trailing returns or rolling returns: Which one to choose?

Shashikant Singh Article rating: 3.0

Returns are one of the most important statistics an investor considers before investing. Read on to find out the difference between a trailing return & a rolling return and also know which one is better.

Kirloskar Ferrous Industries to acquire pig iron plant of VSL Steels
Kirloskar Ferrous Industries to acquire pig iron plant of VSL Steels

Kirloskar Ferrous Industries to acquire pig iron plant of VSL Steels

Amir Shaikh Article rating: 3.8

Kirloskar Ferrous Industries informed the bourses during the weekend that its board of directors at a meeting held on September 12, 2020, has granted in-principle approval for the acquisition of movable & immovable assets relating to the pig iron plant of VSL Steels for a cash consideration of not exceeding Rs 135 crore, payable in installments

Indoco Remedies soars 13 per cent on getting ANDA approval
Indoco Remedies soars 13 per cent on getting ANDA approval

Indoco Remedies soars 13 per cent on getting ANDA approval

Amir Shaikh Article rating: 4.5

Indoco Remedies informed the bourses today that it has received approval for its ANDA for Apixaban tablets 2.5 mg & 5 mg. The products are therapeutically equivalent to the reference listed drug ‘Eliquis’ of Bristol-Myers Squibb (BMS)

India GDP likely to see sharper contraction of 8-8.2 per cent in FY21: CARE Ratings
India GDP likely to see sharper contraction of 8-8.2 per cent in FY21: CARE Ratings

India GDP likely to see sharper contraction of 8-8.2 per cent in FY21: CARE Ratings

Nidhi Jani Article rating: 4.8

It noted that the GDP fall of about 24 per cent in the first quarter was slightly higher than its expectations of a 20.2 per cent contraction. The element, which came in as a surprise, was the growth of public administration, defence, and other services segments at (-) 10.3 per cent.

RSS
First21102111211221132115211721182119Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR